Skip to main content
PLOS One logoLink to PLOS One
. 2024 Aug 28;19(8):e0309226. doi: 10.1371/journal.pone.0309226

Accurate statistical methods to cover the aspects of the increase in the incidence of kidney failure: A survey study in Ha’il -Saudi Arabia

Alanazi Talal Abdulrahman 1,*, Dalia Kamal Alnagar 2
Editor: V Vinoth Kumar3
PMCID: PMC11357112  PMID: 39197066

Abstract

Introduction

Chronic kidney disease (CKD) has become more common in recent decades, putting significant strain on healthcare systems worldwide. CKD is a global health issue that can lead to severe complications such as kidney failure and death.

Objective

The purpose of this study was to investigate the actual causes of the alarming increase of kidney failure cases in Saudi Arabia using the supersaturated design analysis and edge design analysis.

Materials and methods

A cross-sectional questionnaire was distributed to the general population in the KSA, and data were collected using Google Forms. A total of 401 responses were received. To determine the actual causes of kidney failure, edge and supersaturated designs analysis methods were used, which resulted in statistical significance. All variables were studied from factor h1 to factor h18 related to the causes of kidney failure.

Results

The supersaturated analysis method revealed that the reasons for the increase in kidney failure cases are as follows: h9(Bad diet), h8(Recurrent urinary tract infection), h1 (Not drinking fluids), h6 (Lack of exercise), h14 (drinking from places not designated for valleys and reefs), h18 (Rheumatic diseases), h10 (Smoking and alcohol consumption), h13 (Direct damage to the kidneys), h2 (take medications), h17 (excessive intake of soft drinks), h12 (Infection), h5 (heart disease), h3 (diabetes), h4 (pressure disease), h15 (Dyes used in X-rays), and h11 (The presence of kidney stones) are all valid. The design analysis method by edges revealed that the following factors contributed to an increase in kidney failure cases: h8 (Recurrent urinary tract infection), h6 (Lack of exercise), h7 (Obesity), and h11.

Conclusion

The findings showed that there were causes of kidney failure that led to the statistical significance, which is h8 (Recurrent urinary tract infection) and h11 (The presence of kidney stones)

1. Introduction

The kidney is considered one of the most essential parts of the human body as it acts as a filter to purify fluids and blood from impurities eliminate waste and toxic substances in the blood and excrete them outside the body through urine, in addition to controlling the number of fluids, sodium and potassium present in the body. Kidney failure occurs when the kidneys cannot effectively eliminate the waste products. Kidneys may lose the ability to filter waste and excrete liquid waste through urine, resulting in a chronic or acute condition known as kidney failure. In addition, it causes an imbalance in the level of water, mineral salts, and various minerals in the body, which leads to disturbances in the body’s systems, it may threaten life if it is not treated immediately [1]. Chronic kidney disease (CKD) has become more common in recent decades, putting a significant strain on healthcare systems worldwide. CKD is a global health issue that can lead to severe complications such as kidney failure and death. It affects 195 million women worldwide annually and is currently the eighth leading cause of death in women, accounting for 600,000 deaths each year [2]. Patients with end-stage kidney disease (ESKD) have a 17-fold higher mortality rate than age- and sex-matched healthy people. 5 The number of deaths from CKD is expected to reach 2–4 million by 2040 [3]. According to an epidemiological survey conducted in 2010, the global prevalence of CKD was 9.1%, with 697.5 million cases of CKD (all stages) reported worldwide. In contrast, the prevalence of CKD in the Kingdom of Saudi Arabia is 5.7%, posing a significant burden on the healthcare systems. In recent years, the medical literature and community have widely accepted that CKD is associated with an increased risk of premature death [4]. The Executive Director General of the Prince Salman Center for Kidney Diseases and the General Supervisor of the Awareness Campaign for Kidney Diseases, Dr. Khaled bin Abdulaziz Al-Saaran, revealed that the incidence of kidney failure in the Kingdom ranges from 90 to 110 people per million people in the Kingdom who suffer from kidney failure. The incidence of kidney failure in the northern part of the kingdom is the highest compared that on to other regions of the Kingdom, reaching 167 per million people. Some studies indicate that the global incidence of kidney disease is one out of every ten healthy people. The latest kidney failure statistics showed that the total number of patients with chronic renal failure reached 21,000 in Saudi Arabia. According to the Saudi Center for Organ Transplantation annual report, most patients were men 56% and women 44%. During our simple survey ten years ago, the number of people with kidney failure in Saudi Arabia was approximately 9,600 in Saudi [5].

Compared with latest statistics, we find that the number is increasing significantly and is being observed by the competent authorities. However, we did not find a survey study that looked for the reasons for the increase in cases of kidney failure worldwide, as researchers were limited during the past years to treat only in the advanced stages and urging early detection of this disease.

This study aimed to identify the reasons for the increase in kidney failure cases by conducting a survey using various statistical models. Additionally, this study examines two methods, a supersaturated design and an edge design supersaturated design, to identify the actual reasons for the increase in kidney failure cases.

Supersaturated Design Analysis is a statistical approach used in experiments in which the number of factors exceeds the number of runs. This is useful when it is believed that only a few factors are significant and particularly beneficial for screening purposes. These designs are known for their run-size economy and have been proven to be effective in identifying significant factors [68]. Edge design analysis refers to the study and evaluation of experimental designs that are particularly useful for screening experiments with more factors than runs. These designs help identify the most influential factors with a limited number of experiments; in addition, the analysis of edge designs often involves statistical methods to assess the robustness and efficiency of the designs [9].

The validity of the two methods, Analysis by supersaturated designs and analysis by design with edges, can be assessed based on their effectiveness in identifying significant factors in an experimental setup.

2. Materials and methods

2.1. Survey study

This section contains general questions related to metadata and causes of kidney failure. The general questions included gender, age, region, a chronic disease, and kidney failure. Regarding the questions related to the causes of kidney failure, where the opinion of the competent people, the patient, or those around the patient is taken about the actual cause from his simple point of view for the following reasons:

  • h1: Not drinking fluids

  • h2: Take medications

  • h3: Diabetes

  • h4: Pressure disease

  • h5: heart disease

  • h6: Lack of exercise

  • h7: Obesity

  • h8: Recurrent urinary tract infection

  • h9: Bad diet

  • h10: Smoking and alcohol consumption

  • h11: The presence of kidney stones

  • h12: Infection

  • h13 Direct damage to the kidneys

  • h14: Drinking from places not designated for valleys and reefs

  • h15: Dyes used in x-rays

  • h16: Stress and lack of sleep

  • h17: Excessive intake of soft drinks

  • h18: Rheumatic diseases

  • Y: How many cases do you know of that have kidney failure?

2.2. The recruitment period and ethics statement

After obtaining approval from the Research Ethics Committee, the questionnaire was distributed to the target group from 01/24/2023 to 06/24/2023. The Research Ethics Committee (RCE) at the University of Ha’il reviewed and approved this study on January (23, 2023, research number H-2023-040). Verbal and written consent were obtained from all participants prior to data collection.

2.3. Methods used in the analysis

2.3.1. Analysis by supersaturated designs

Contrast method analysis with supersaturated designs was used to determine the causes of kidney failure, which were statistically significant. The procedure is as follows, [10].

  1. Discover all factors that are distinct through the equation:

  2. Begin with I = 0 and work your way up to p = N/2, where N is the number of trials.

  3. Look for the following equations:

M=XTY, (1)

Y is the response factor, and X is the design chosen from the graphic survey. At this point, the superior attributes and ranking factors express contracts.

umli=|mk|tk1,α2σp (2)
lmli=|mk|+tk1,α2σp, (3)

where tk1,α2 is the relative distribution of the t table.

  1. Remove the highest valued |mk−1| and then set I = I + 1.

  2. Find the σp for the p most significant supreme differences using only the leftover qualities.

  3. From Eqs (2) and (3), if the fluctuation in E is less than the difference found before Step 3, proceed to Step 5; otherwise, stop and close the dynamic components from the differences outside the primary district.

  4. More details on this method can be found in reference [11].

2.3.2. Analysis by design with edges

Edge designs analysis was used to determine the actual causes of kidney failure, which resulted in the statistical significance. The procedure described in [12] is as follows.

  1. Find zi,j = yiyj, (i, j) ϵ E.

  2. After determined the values of the active factors, the absolute value of all values was found and arranged in descending order.

  3. We start with the value p zero and find the median for all the values of the first step, considering that the values of p depend on the values of Z.

  4. Find

  5. σ = |med{zi,j:(i,j)ϵE}0.6752|

  6. We calculate this equation: k×2^0.5 σ(p)

Based on the previous step, we searched for the number of active w (p) agents based on the value of Z.

More details on this method can be found in reference [13].

2.4. Combine the results of the two methods

In this section, models and applications for each method are selected, and the analysis was used by a saturated design for each particular model of this method to search for the reasons that led to an increase in cases of kidney failure. Then, the edge analysis method was used for the aforementioned selected model and design to search for the reasons. In the end, similar causes were identified in both methods, therefore, these are the actual reasons that led to increased cases of kidney failure.

3. Results

3.1. The results of the general data analysis

This section presents the results of the questionnaire answers to the general questions related to our research.

Fig 1 shows the responses to the questionnaires according to age. The age group from 18 to 25 constituted 52 percent as the highest response rate, followed by the age group from 26 to 35 (20%), and the age group from 36 to 50 (19%). While the age group over 50 years achieved a low percentage of the questionnaire responses, at 9 percent. Fig 2 shows that the response rate of the questionnaire for males was equal to the response rate for females. Fig 3 shows the response rate for each region, as the northern region occupied the highest response rate, estimated at 52%, followed by the central area at 23%, while the rest of the regions are as shown in the figure. Fig 4 shows whether those who answered the questionnaire had chronic disease and kidney failure, where the highest percentage was that they did not have these diseases.

Fig 1. The percentage of response by age.

Fig 1

Fig 2. The rate of gender responses.

Fig 2

Fig 3. The rate of region responses.

Fig 3

Fig 4. Percentage of chronic disease and Kidney failure or not.

Fig 4

3.2. Analysis results of the supersaturated designs method

In this section, applications are made for the questionnaire, which consists of a supersaturated design so that the number of influencing factors is greater than the number of responses at one rate. The above analysis method was then used.

3.2.1. Application 1

We assumed that n = 17, as shown in Table 1. The authors employed the aforementioned analysis techniques. The Eq 1 used to find all factor contrasts, calculate absolutes, and sort these values. The outcomes are presented in Table 2. Set I to 0 and compute the variance of the p most significant absolute contracts (using p = N/2, where N is the run size). Table 3 shows the outcome. The authors noticed that σ22 is greater than σ12, so we stopped and looked for the active factors. The final values of Stage 1’s are umli = 25.10, lmli = -25.10 and σ12 = 22. Consequently, the following active factors exist outside the critical region: h9,h8,h1,h6,h14, and h18.

Table 1. The first supersaturated application of the questionnaire.
h 1 + + + + + + + - + + + + + + - + +
h 2 - + - + + - - - + + + + - - + + -
h 3 + - - - + - - - - + + + + - + + -
h 4 + - - - + - - - - + + + + - - + +
h 5 + - - - + - - - - + + + + - - + -
h 6 - + + - + - + - + + + + - + + + +
h 7 + - + - + - + - - + - + - + - - -
h 8 + - + - + - + + + + - + + + + - +
h 9 + + + - + + + + + + + + + - + - -
h 10 + + + + + - + - + + + + + + - + -
h 11 + + + + + + - + + + + + - + - + -
h 12 + - + + - - + - - + + + - - + + -
h 13 + + + + + + - + + + + + - + - + -
h 14 + + + - + - - - + + + + + - + - -
h 15 - - + + + - - - + + + + + - - + -
h 16 - - + + - + + - - - + + - - + - -
h 17 + + + - + + + - + + + + + + - - +
h 18 - - - - - - - - - - + + - - + - -
Y 2 3 8 4 7 2 2 1 2 5 1 3 2 1 10 0 2
Table 2. Sorted absolute contrasts for Application 1.
J 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
h n h 9 h 8 h 1 h 6 h 14 h 18 h 10 h 17 h 11 h 13 h 2 h 5 h 12 h 4 h 15 h 3 h 16 h 7
|M(j)| 41 35 33 33 31 27 25 25 23 23 15 15 15 11 9 5 5 1
Table 3. Step-by-step calculations for Application 1.
i σi2 uml i lml i σi2>σi12
0 34 28.74 -28.74 -
1 22 25.10 -25.10 No
2 33.11 20.80 -20.80 Yes

3.2.2. Application 2

We assume that n = 17, as listed in Table 4. The authors employed the aforementioned analysis techniques. The Eq 1 was used to find all factor contrasts, calculate absolutes, and sort these values. Table 5 shows the result. We set I to 0 and compute the variance of the p most significant absolute contracts (using p = N/2, where N is the run size). The outcomes were presented in Table 6. The authors noticed that σ22 is greater than σ12, so we stopped and looked for the active factors. The final values in Stage 1’s is umli = 14.35, lmli = -14.35 and σ12 = 13.11. As a result, the following active factors exist outside the critical region: h10,h13,h1,h2,h8,h9, and h17.

Table 4. The second supersaturated application of the questionnaire.
h 1 + + + - + + + - + + + + + + + + -
h 2 + + + - + + + + + + + + + + + + -
h 3 + + + - + - + - - + - - + + + + -
h 4 + + + - - - + - - + - - - + + + -
h 5 + + + - + - - - - - - + - + + + -
h 6 + + + + - - - + - + - + + + + + +
h 7 + + + + + + - + + - - - + + + + +
h 8 + + + - + + + + - - - + - + + + -
h 9 + + + + - + + + + + + - + + + + +
h 10 + + + - + + + + + - + + + + + + -
h 11 + + - - + + + + + + + + + + + - -
h 12 + + - - - - - + - + - - - + + - -
h 13 + + + - + + + + + + + - + + + + -
h 14 + + - - + + - + - + + + + + + - -
h 15 + + - - - - + + - - + + + + + - -
h 16 + + - - - - - + - - - - + + + - -
h 17 + + + - + + - + + + + + + + + + -
h 18 + + - - + - - + - - + - - + + - -
Y 2 2 5 1 2 3 2 2 0 2 1 2 1 0 0 1 2
Table 5. Sorted absolute contrasts for Application 2.
J 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
h n h 10 h 13 h 1 h 2 h 8 h 9 h 17 h 7 h 12 h 14 h 5 h 11 h 3 h 18 h 6 h 4 h 15 h 16
|M(j)| 24 22 20 20 18 18 18 14 12 12 10 10 8 8 6 4 4 4
Table 6. Step-by-step calculations for Application 2.
i σi2 uml i lml i σi2>σi12
0 13.77 16.20 -16.20 -
1 13.11 14.35 -14.35 No
2 14.44 11.94 -11.94 Yes

3.2.3. Application 3

We assume that n = 17, as listed in Table 7. The authors employed the techniques mentioned above to analyze the situation. Eq 1 was used to find all factor contrasts, calculate absolutes, and sort these values. The outcomes were presented in Table 8. We set I to 0 and compute the variance of the p most significant absolute contracts (using p = N/2, where N is the run size). Table 9 showed the result. The authors noticed that σ12 is greater than σ02, we stopped and looked for the active factors. Stage 1’s final values are umli = 35.19, lmli = -35.19 and σ02 = 21.77. Consequently, the following active factors exist outside the critical region: h1,h17,h9,h11,h13, and h8.

Table 7. The third supersaturated application of the questionnaire.
h 1 + + + + + + + + + + + + + + + + +
h 2 + + - + + + + + + + + - + - - + +
h 3 + - - - + - - + + - + - + - + + -
h 4 + - - - + - - - + - + - + - + + -
h 5 - + - - - + - - + - - - + - - - -
h 6 - + - + + - + + + + - + + + + - -
h 7 - + - + + - - + + - - + + + - - -
h 8 + + + + + - + + + - + + + + + - -
h 9 + + + + + + + + + + + + + + - - +
h 10 + + - + + + - + + - + - + + + + +
h 11 + + - + + - + + + - + + + + + + +
h 12 - + - - - - + + + - + - + - + + -
h 13 - + - + + + + + + + + + + + + + +
h 14 - + - - - + + + + + + - + - + - +
h 15 - + - + - - + + + - + - + - - - -
h 16 - + + - + - + - + - - - + + + - -
h 17 + + + + + - + + + + + + + + + - +
h 18 - + - - - - - - + - + - + - - - -
Y 2 3 0 2 1 0 3 1 18 2 2 1 3 4 1 1 1
Table 8. Sorted absolute contrasts for Application 3.
J 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
h n h 1 h 17 h 9 h 11 h 13 h 8 h 2 h 6 h 10 h 14 h 7 h 16 h 12 h 15 h 3 h 4 h 5 h 18
|M(j)| 45 43 41 41 41 37 33 33 33 23 21 21 19 19 13 11 7 3
Table 9. Step-by-step calculations for Application 3.
i σi2 uml i lml i σi2>σi12
0 21.77 35.19 -35.19 -
1 40.11 31.63 -31.63 Yes
2 14.44 11.94 -11.94 Yes

3.2.4. Application 4

We assume that n = 17, as listed in Table 10. The authors employed the aforementioned techniques for the analysis. Eq 1 was used to find all factor contrasts, calculate absolutes, and sort these values. The result presented in Table 11. We set I to 0 and compute the variance of the p most significant absolute contracts (using p = N/2, where N is the run size). The outcomes were presented in Table 12. The authors noticed that σ32 is greater than σ22, so we stopped and looked for the active factors. Stage 1’s final values are umli = 34.76, lmli = -34.76 and σ22 = 4. Consequently, the following active factors exist outside the critical region: h18,h12,h5,h3,h4,h15,h9,h10 and h11.

Table 10. The fourth supersaturated application of the questionnaire.
h 1 + - + + + - + + + + - + + + + + +
h 2 + - + + + - + - + + - + + + + - +
h 3 - + + - - - + + + + - - - - + - -
h 4 - + + - - - + + - + - - + - + - -
h 5 - + - - - - + + - + - - - - - - -
h 6 - + - + + - + + + + - + + - + + +
h 7 - - - - + - + + + + - + + - + + +
h 8 + - + - - - + + + + - + + - + + +
h 9 + + + + + - + + + + - + + + + + +
h 10 + + + + + - + + + + - + - + + + +
h 11 + + + - + - + + + + - + + + + + +
h 12 - - - + - - + + + + - + + - - - -
h 13 + - + + + - + + + + - + + + + + +
h 14 + - - + + - + + + + - + + + + + +
h 15 - + + - - - + + + + - + + - + - -
h 16 - - - - + - + - - + - + + - - + -
h 17 - + + - + - + + + + - + + + + + -
h 18 - + - - - - + - - + - - - - + - -
Y 25 1 1 0 9 2 1 3 0 1 6 0 0 1 0 0 1
Table 11. Sorted absolute contrasts for Application 4.
J 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
h n h 18 h 12 h 5 h 3 h 4 h 15 h 9 h 10 h 11 h 1 h 13 h 14 h 16 h 2 h 7 h 6 h 17 h 8
|M(j)| 45 41 39 37 37 37 35 35 35 33 33 31 29 27 21 19 17 13
Table 12. Step-by-step calculations for Application 4.
i σi2 uml i lml i σi2>σi12
0 11.11 37.99 -37.99 -
1 5.77 35.92 -35.92 No
2 4 34.76 -34.76 No
3 4.44 32.50 -32.50 Yes

3.3. Analysis results of the edges design method

In this section, a ready-made edge design is selected from a published scientific paper consisting of six factors and 12 runs (N) [14,15]. This design was examined horizontally to ensure agreement with the questionnaire’s design. The chosen design was then analyzed by designing the above edges. The design chosen from the scientific literature is as follows.

1 1 -1 1 1 1
-1 1 1 1 1 1
1 -1 1 1 1 1
-1 -1 -1 1 -1 1
-1 -1 -1 1 1 -1
-1 -1 -1 -1 1 1
-1 1 -1 1 1 1
-1 -1 1 1 1 1
1 -1 -1 1 1 1
-1 -1 -1 -1 -1 1
-1 -1 -1 1 -1 -1
-1 -1 -1 -1 1 -1

3.3.1. The first design with the edges of the questionnaire

The following is an edge design analysis of the data in Table 13. To begin, Table 14 shows that all six contrasts of response y over the edges and the absolute regard are present. Second, we computed the center to forecast the number p as a powerful part. Third, we discovered (σ), w (p), and k^2^0.5. Finally, if w (p) for some hypothesis p is more critical than p, the method is terminated, and a unique factor is sought. The results are shown in Table 15; We have w (2) = 1, indicating a unique factor, which is h8 (Recurrent urinary tract infection).

Table 13. The first design with the edges of the questionnaire.
N\ Factor h 3 h 4 h 5 h 6 h 7 h 8 Y
1 1 1 -1 1 1 1 1
2 -1 1 1 1 1 1 2
3 1 -1 1 1 1 1 2
4 -1 -1 -1 1 -1 1 2
5 -1 -1 -1 1 1 -1 2
6 -1 -1 -1 -1 1 1 2
7 -1 1 -1 1 1 1 1
8 -1 -1 1 1 1 1 3
9 1 -1 -1 1 1 1 1
10 -1 -1 -1 -1 -1 1 1
11 -1 -1 -1 1 -1 -1 3
12 -1 -1 -1 -1 1 -1 0
Table 14. Model-free tests with an edge plan.
h 3 h 4 h 5 h 6 h 7 h 8
0 -1 1 1 -1 2
0 1 1 1 1 2
Table 15. Step estimations for the edge plan investigation.
p Median σ(p)
e
k×20.5σ(p) ω(p) ω(p) < p?
0 1 1.047565602 1.481481481 1 No
1 1 1.047565602 1.481481481 1 No
2 1 1.047565602 1.481481481 1 Yes

3.3.2. The second design with the edges of the questionnaire

The following is an edge design analysis of the data in Table 16. All six contrasts of response y over the edges and the absolute regard are presented in Table 17. Second, we computed the center to forecast the number p as powerful parts. Third, we discovered (σ), w (p), and k^2^0.5. Finally, if the w (p) for some hypothesis p is more critical than p, the method is terminated, and a unique factor is sought. The results are listed in Table 18; where w (5) = 4., indicating that there are unique factors h6 (Lack of exercise), h7 (Obesity), h8 (Recurrent urinary tract infection) and h11 (presence of kidney stones).

Table 16. The second design with the edges of the questionnaire.
N\ Factor h 6 h 7 h 8 h 9 h 10 h 11 Y
1 1 1 -1 1 1 1 2
2 -1 1 1 1 1 1 2
3 1 -1 1 1 1 1 2
4 -1 -1 -1 1 -1 1 2
5 -1 -1 -1 1 1 -1 0
6 -1 -1 -1 -1 1 1 4
7 -1 1 -1 1 1 1 1
8 -1 -1 1 1 1 1 1
9 1 -1 -1 1 1 1 3
10 -1 -1 -1 -1 -1 1 2
11 -1 -1 -1 1 -1 -1 0
12 -1 -1 -1 -1 1 -1 0
Table 17. Model-free tests with an edge plan.
h 6 h 7 h 8 h 9 h 10 h 11
1 1 -1 0 0 4
1 1 1 0 0 4
Table 18. Step estimations for the edge plan investigation.
p Median σ(p)
e
k×20.5σ(p) ω(p) ω(p) < p?
0 1 1.047565602 1.481481481 1 No
1 1 1.047565602 1.481481481 1 No
2 0.5 0.523782801 0.740740741 4 No
3 0 0 0 4 No
4 0 0 0 4 No
5 0 0 0 4 Yes

4. Discussion and conclusion

CKD is a global health issue that can lead to severe complications such as kidney failure and death. It affects 195 million women worldwide each year and is currently the eighth leading cause of death in women, accounting for 600,000 deaths annually. This study aimed to identify the actual causes that leading to an increase in kidney failure cases using supersaturated and edge design analysis methods. Models of designs were used for each method using applications resulting from the questionnaire to achieve this goal. Applications were used for each technique in the analysis. The analysis method using supersaturated designs revealed that the reasons for the increase in kidney failure cases were as follows: h9,h8,h1,h6,h14,h18,h10,h13,h2,h17,h11,h12,h5,h3,h4,h15 and h11. At the same time, the design analysis method by edges gave that the reasons that led to an increase in kidney failure cases: h8,h6,h7, and h11. Finally, the similar reasons in the two methods are h6 (Lack of exercise), h8 (Recurrent urinary tract infection), and h11 (The presence of kidney stones). The Saudi government, represented by the Ministry of Health, should publish periodic and cultural publications to educate the community about these reasons, urging them to practice sports and the early detection of stones and urinary tract infections.

Supporting information

S1 Data

(PDF)

pone.0309226.s001.pdf (614.7KB, pdf)

Acknowledgments

This research was funded by the Scientific Research Deanship at the University of Ha’il, Saudi Arabia, project number RD-21 001.

Data Availability

The authors confirm that the data supporting the findings of this study are available within the article [and/or] its supplementary materials.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Al-Nour Samira, & El-Derazi. (2019). The main causes of end renal failure. Sebha University digital repository in Libya. [Google Scholar]
  • 2.Kovesdy C. P. (2022). Epidemiology of chronic kidney disease: an update 2022. Kidney International Supplements, 12(1), 7–11. doi: 10.1016/j.kisu.2021.11.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Ahmed H. G., Alzayed F. S. M., Albluwe H. K. A., Alosayfir Z. A. S., Aljarallah M. Y. J., Alghazi B. K. M., & Alshammari M. A. G. (2019). Etiology of chronic kidney disease (ckd) in Saudi Arabia. International Journal of Medical Research & Health Sciences, 8(5), 177–182. [Google Scholar]
  • 4.Alghamdi A., Alaryni A., AlMatham K., Hakami O., Qutob R., Bukhari A.,… & Abdullah A. (2023). Knowledge, Attitudes, and Practices of High-Risk Patients towards Prevention and Early Detection of Chronic Kidney Disease (CKD) in Saudi Arabia. International Journal of Environmental Research and Public Health, 20(1), 871. doi: 10.3390/ijerph20010871 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Alsaqa’aby M., Alissa D., Hussein M., Almudaiheem H. Y., & Al-Jedai A. (2023). Cost-Utility of Immunosuppressive Therapy Post-Renal Transplantation in Saudi Arabia: The Saudi Ministry of Health Perspective. Value in Health Regional Issues, 33, 56–64. doi: 10.1016/j.vhri.2022.08.014 [DOI] [PubMed] [Google Scholar]
  • 6.Dejaegher B., & Vander Heyden Y. (2008). Supersaturated designs: set-ups, data interpretation, and analytical applications. Analytical and bioanalytical chemistry, 390, 1227–1240. doi: 10.1007/s00216-007-1641-0 [DOI] [PubMed] [Google Scholar]
  • 7.Georgiou S. D. (2014). Supersaturated designs: A review of their construction and analysis. Journal of Statistical Planning and Inference, 144, 92–109. [Google Scholar]
  • 8.Phoa F. K., Pan Y. H., & Xu H. (2009). Analysis of supersaturated designs via the Dantzig selector. Journal of Statistical Planning and Inference, 139(7), 2362–2372. [Google Scholar]
  • 9.Benedetti B., Caponigro V., & Ardini F. (2022). Experimental design step by step: a practical guide for beginners. Critical Reviews in Analytical Chemistry, 52(5), 1015–1028. [DOI] [PubMed] [Google Scholar]
  • 10.Alanazi Talal Abdulrahman Randa Alharbi, Alamri Osama, Alnagar Dalia, Alruwaili Bader (2021). Application of Supersaturated Design to Study the Spread of Electronic Games. Mathematics and Statistics, 9(3), 278–284. doi: 10.13189/ms.2021.090308 [DOI] [Google Scholar]
  • 11.Koukouvinos C., & Stylianou S. (2005). A method for analyzing supersaturated designs. Communications in Statistics—Simulation and Computation®, 34(4), 929–937. [Google Scholar]
  • 12.Alanazi Talal Abdulrahman Adel A. Attiya, "Mathematical and Statistical Models with Applications of Spread of Private Tutoring in Saudi Arabia", Complexity, vol. 2022, Article ID 7842971, 9 pages, 2022. doi: 10.1155/2022/7842971 [DOI] [Google Scholar]
  • 13.Elster C.; Neumaier A. Screening by conference designs. Biometrika. (1995). 82(3):589–602. [Google Scholar]
  • 14.Alanazi T., Georgiou S. D., & Stylianou S. (2018). Construction and analysis of edge designs from skew-symmetric supplementary difference sets. Communications in Statistics-Theory and Methods, 47(20), 5064–5076. [Google Scholar]
  • 15.Alanazi, T. (2018). Construction and analysis of experimental designs (Doctoral dissertation, RMIT University). [

Decision Letter 0

V Vinoth Kumar

21 Feb 2024

PONE-D-23-22130Accurate statistical methods to cover the aspects of the increase in the incidence of kidney failure: a survey study in Saudi ArabiaPLOS ONE

Dear Dr. Abdulrahman,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Apr 06 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

V. Vinoth Kumar

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Note from Emily Chenette, Editor in Chief of PLOS ONE, and Iain Hrynaszkiewicz, Director of Open Research Solutions at PLOS: Did you know that depositing data in a repository is associated with up to a 25% citation advantage (https://doi.org/10.1371/journal.pone.0230416)? If you’ve not already done so, consider depositing your raw data in a repository to ensure your work is read, appreciated and cited by the largest possible audience. You’ll also earn an Accessible Data icon on your published paper if you deposit your data in any participating repository (https://plos.org/open-science/open-data/#accessible-data).

3. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information.

4. Thank you for stating the following financial disclosure: 

   "There are no founding"

At this time, please address the following queries:

a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution. 

b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

c) If any authors received a salary from any of your funders, please state which authors and which funders.

d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

5. In the online submission form, you indicated that "The data supporting the study's findings are available upon request from the corresponding author"

All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 1. In a public repository, 2. Within the manuscript itself, or 3. Uploaded as supplementary information.

This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval. 

6. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section. 

7. Please ensure that you refer to Figure 4 in your text as, if accepted, production will need this reference to link the reader to the figure.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: 1. Related works must be presented elaboratively.

2. Number of references needs to be increased

3. Significance of the work needs to be highlighted clearly

4. English language needs to be rechecked and minor corrections are necessary.

Reviewer #2: 1. Abstract: result section: the ℎ9, ℎ8, ℎ1,

ℎ6, ℎ14, ℎ18, need to be clarified for the readers. I suggest the authors should use the actual findings so as to be easily identified by the readers.

2. body of the paper: result section: the repetition of the words [[EQUATION]], [[EQUATION]] may not be understood to the readers, can use other forms of findings, so as to be easily read by the readers? Also this is observed in he conclusion section.

3. The author should identify the validity of the two methods: Analysis by supersaturated designs and Analysis by design with edges. Are these methods compared to other developed methods?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Bharanidharan N

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Aug 28;19(8):e0309226. doi: 10.1371/journal.pone.0309226.r002

Author response to Decision Letter 0


25 Apr 2024

Dear Reviewer, 1

I would like to say thank you for the very excellent comments, which add a very wonderful addition to the scientific paper. The following table shows the addition by the authors.

Reviewer 1 comments Authors comments

Related works must be presented elaboratively Done in third paragraph from introduction section

Number of references needs to be increased Done we added refences 6, 7, 8, 9 and 15

Significance of the work needs to be highlighted clearly Done in second paragraph from introduction section that: The study aims to identify the actual reasons…

English language needs to be rechecked and minor corrections are necessary Done. We highlighted as follow:

- Line 3, 4, 5, 18 in abstract

- Line 3, 5 , 27 in introduction

- Subsection 2.3.1 step 5 : differences.

- Third line in conclusion.

Dear Reviewer, 2

I would like to say thank you for the very excellent comments, which add a very wonderful addition to the scientific paper. The following table shows the addition by the authors.

Reviewer 2 comments Authors comments

Abstract: result section: the ℎ9, ℎ8, ℎ1,

ℎ6, ℎ14, ℎ18, need to be clarified for the readers. I suggest the authors should use the actual findings to be easily identified by the readers. Done. We use the actual finding in abstract

body of the paper: result section: the repetition of the words [[EQUATION]], [[EQUATION]] may not be understood to the readers, can use other forms of findings, so as to be easily read by the readers? Also this is observed in the conclusion section. Done in subsection 2.3.1

The author should identify the validity of the two methods: Analysis by supersaturated designs and Analysis by design with edges. Are these methods compared to other developed methods? Done in fourth paragraph from introduction section that The validity of the two methods….

Authors

Dr Talal

Dr Dalia

Attachment

Submitted filename: Comments.docx

pone.0309226.s002.docx (17.1KB, docx)

Decision Letter 1

V Vinoth Kumar

18 Jun 2024

PONE-D-23-22130R1Accurate statistical methods to cover the aspects of the increase in the incidence of kidney failure: a survey study in Ha'il -Saudi ArabiaPLOS ONE

Dear Dr. Abdulrahman,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 02 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

V. Vinoth Kumar

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: All suggestions are incorporated by the authors.

Only minor language corrections are required before publishing the manuscript.

Reviewer #2: There minor comments in methodology sections. In section 2.4: Combine the results of the two methods. The authors use the future tense, I suggest to use the past tense since the procedure or tests had already been applied. Secondly in abstract section the sentence(All variables are studied from to) is incomplete.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Moawia Gameraddin

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Aug 28;19(8):e0309226. doi: 10.1371/journal.pone.0309226.r004

Author response to Decision Letter 1


18 Jul 2024

Dear Reviewers

I would like to say thank you for the very excellent comments, which add a very wonderful addition to the scientific paper. The following table shows the addition by the authors in the attachment

Decision Letter 2

V Vinoth Kumar

8 Aug 2024

Accurate statistical methods to cover the aspects of the increase in the incidence of kidney failure: a survey study in Ha'il -Saudi Arabia

PONE-D-23-22130R2

Dear Dr. Abdulrahman,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

V. Vinoth Kumar

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: All the comments have been satisfied. In methodology section, I suggest the authors to validate the Methods which were used in the analysis.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

**********

Acceptance letter

V Vinoth Kumar

19 Aug 2024

PONE-D-23-22130R2

PLOS ONE

Dear Dr. Abdulrahman,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. V. Vinoth Kumar

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Data

    (PDF)

    pone.0309226.s001.pdf (614.7KB, pdf)
    Attachment

    Submitted filename: Comments.docx

    pone.0309226.s002.docx (17.1KB, docx)

    Data Availability Statement

    The authors confirm that the data supporting the findings of this study are available within the article [and/or] its supplementary materials.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES